Pediatric reference intervals determined in ambulatory and hospitalized children and juveniles

Matthias Heiduk1, Ilona Päge, Cordula Kliem

  • 1University Hospital Magdeburg, Children's Hospital, Magdeburg, Germany.

Insights

This study establishes pediatric reference intervals for nine common lab tests, including enzyme methods and biomarkers like soluble transferrin receptor (sTfR) and ferritin. Results provide updated reference ranges crucial for accurate clinical interpretation in children and juveniles.

Area of Science:

  • Clinical Chemistry
  • Pediatric Laboratory Medicine
  • Biomarker Analysis

Background:

  • Accurate laboratory reference intervals are essential for diagnosing and monitoring pediatric health conditions.
  • Established reference ranges for many laboratory methods, particularly newer ones, require periodic validation in pediatric populations.
  • Age and gender are known factors influencing many biochemical markers in children.

Purpose of the Study:

  • To determine pediatric reference intervals for nine widely used laboratory methods.
  • To establish age- and gender-specific reference ranges for clinical use in children and juveniles.
  • To compare newly derived reference intervals with previously reported values, especially for novel biomarkers.

Main Methods:

  • Analysis of over 800 pediatric patients (1 day to 17 years) with diverse clinical statuses.
  • Selection of a reference group with balanced gender and age distribution across five age classes.
  • Utilized enzyme methods (ALT, AST, LDH, GGT, ALP) and biomarkers (sTfR, ferritin) standardized to IFCC guidelines where applicable.

Main Results:

  • Confirmed typical age-related concentration patterns for most measured analytes.
  • Identified distinct differences in reference limits for soluble transferrin receptor (sTfR) and ferritin compared to prior studies.
  • Statistical analysis revealed significant gender-specific differences for certain laboratory parameters.

Conclusions:

  • Proposed reference intervals based on the central 95th percentile values.
  • The findings provide updated, clinically relevant reference ranges for pediatric laboratory testing.
  • Highlights the need for method-specific and age-stratified reference intervals in pediatrics.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...